CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $293,113 | -44.1% | 46,674 | -6.0% | 0.00% | -50.0% |
Q3 2022 | $524,000 | +204.7% | 49,659 | +56.6% | 0.00% | – |
Q2 2022 | $172,000 | -25.2% | 31,707 | +26.3% | 0.00% | – |
Q1 2022 | $230,000 | -39.3% | 25,100 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $379,000 | – | 25,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 674,196 | $10,174,000 | 6.39% |
72 Investment Holdings, LLC | 474,067 | $7,154,000 | 6.35% |
Velan Capital Investment Management LP | 210,695 | $3,179,000 | 2.47% |
PFM Health Sciences, LP | 4,092,309 | $59,418,000 | 2.02% |
Monashee Investment Management LLC | 504,377 | $7,611,000 | 1.88% |
CloudAlpha Capital Management Limited/Hong Kong | 415,000 | $6,262,000 | 1.49% |
Avidity Partners Management LP | 2,674,067 | $40,352,000 | 0.86% |
Rokos Capital Management LLP | 570,359 | $8,604,000 | 0.52% |
Green Alpha Advisors, LLC | 35,592 | $537,000 | 0.36% |
Tekla Capital Management LLC | 699,377 | $9,875,000 | 0.32% |